Using A type botulinum toxin for treating dynamic alar hypertelorism

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033097

Enrollment

Unknown

Registered

2020-05-20

Start date

2020-05-20

Completion date

Unknown

Last updated

2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dynamic alar hypertelorism

Interventions

experimental group:botulinum toxin injection

control group:equal salin injection

Eligibility

Sex/Gender

Female

Age

25 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) Aged 20-35 years, female; (2) Han nationality; (3) BMI:18.5-24.9kg/m2; (4) Voluntary, participant with good compliance.

Exclusion criteria

Exclusion criteria: (1) History of congenital or acquired maxillofacial deformity and nasal deformity; (2) History of severe nasal trauma; (3) History of related diseases affecting nasal muscle movement, such as myasthenia gravis, facial paralysis, scleroderma, etc.; (4) Surgical history affecting nasal muscle continuity or mobility; (5) During pregnancy, pregnancy preparation or lactation.

Design outcomes

Primary

Measure	Time frame
distance between mark points;velocity of movement of mark points;acceleration of mark points;maximum distance of movents of mark points;	—

Countries

China

Contacts

Public ContactCao Dejun

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine

dejuncao@126.com+86 18017856530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026